Logo image of ESF0.DE

EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis

Europe - FRA:ESF0 - FR0014000MR3 - Common Stock

58.06 EUR
0 (0%)
Last: 11/18/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, ESF0 scores 6 out of 10 in our fundamental rating. ESF0 was compared to 18 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of ESF0 get a neutral evaluation. Nothing too spectacular is happening here. ESF0 is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make ESF0 suitable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year ESF0 was profitable.
In the past year ESF0 had a positive cash flow from operations.
In the past 5 years ESF0 has always been profitable.
In the past 5 years ESF0 always reported a positive cash flow from operatings.
ESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

ESF0 has a Return On Assets (3.54%) which is comparable to the rest of the industry.
ESF0's Return On Equity of 8.09% is in line compared to the rest of the industry. ESF0 outperforms 50.00% of its industry peers.
With a decent Return On Invested Capital value of 9.79%, ESF0 is doing good in the industry, outperforming 72.22% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ESF0 is significantly below the industry average of 13.84%.
The last Return On Invested Capital (9.79%) for ESF0 is above the 3 year average (8.70%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.54%
ROE 8.09%
ROIC 9.79%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ESF0.DE Yearly ROA, ROE, ROICESF0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 5.44%, ESF0 is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
ESF0's Profit Margin has improved in the last couple of years.
ESF0 has a Operating Margin (15.59%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ESF0 has grown nicely.
Looking at the Gross Margin, with a value of 23.29%, ESF0 is doing worse than 88.89% of the companies in the same industry.
ESF0's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.59%
PM (TTM) 5.44%
GM 23.29%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
ESF0.DE Yearly Profit, Operating, Gross MarginsESF0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ESF0 is still creating some value.
The number of shares outstanding for ESF0 has been reduced compared to 1 year ago.
The number of shares outstanding for ESF0 has been increased compared to 5 years ago.
Compared to 1 year ago, ESF0 has an improved debt to assets ratio.
ESF0.DE Yearly Shares OutstandingESF0.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESF0.DE Yearly Total Debt VS Total AssetsESF0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 2.63 indicates that ESF0 is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.63, ESF0 perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
ESF0 has a debt to FCF ratio of 5.25. This is a neutral value as ESF0 would need 5.25 years to pay back of all of its debts.
The Debt to FCF ratio of ESF0 (5.25) is better than 61.11% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that ESF0 is somewhat dependend on debt financing.
ESF0 has a worse Debt to Equity ratio (0.77) than 72.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 5.25
Altman-Z 2.63
ROIC/WACC1.23
WACC7.93%
ESF0.DE Yearly LT Debt VS Equity VS FCFESF0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

ESF0 has a Current Ratio of 1.26. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.26, ESF0 is in line with its industry, outperforming 44.44% of the companies in the same industry.
ESF0 has a Quick Ratio of 1.19. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
ESF0's Quick ratio of 1.19 is amongst the best of the industry. ESF0 outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.19
ESF0.DE Yearly Current Assets VS Current LiabilitesESF0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.50% over the past year.
ESF0 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.34% yearly.
The Revenue has been growing slightly by 2.53% in the past year.
The Revenue has been growing by 8.78% on average over the past years. This is quite good.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%

3.2 Future

The Earnings Per Share is expected to grow by 15.60% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.37% on average over the next years.
EPS Next Y14.65%
EPS Next 2Y13.56%
EPS Next 3Y14%
EPS Next 5Y15.6%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.91%
Revenue Next 5Y7.37%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ESF0.DE Yearly Revenue VS EstimatesESF0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
ESF0.DE Yearly EPS VS EstimatesESF0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.13, ESF0 is valued correctly.
Based on the Price/Earnings ratio, ESF0 is valued cheaper than 83.33% of the companies in the same industry.
ESF0's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.46.
Based on the Price/Forward Earnings ratio of 14.58, the valuation of ESF0 can be described as correct.
ESF0's Price/Forward Earnings ratio is rather cheap when compared to the industry. ESF0 is cheaper than 83.33% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.39. ESF0 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 16.13
Fwd PE 14.58
ESF0.DE Price Earnings VS Forward Price EarningsESF0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ESF0 is valued cheaper than 83.33% of the companies in the same industry.
ESF0's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ESF0 is cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.49
EV/EBITDA 8.2
ESF0.DE Per share dataESF0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ESF0 has a very decent profitability rating, which may justify a higher PE ratio.
ESF0's earnings are expected to grow with 14.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.1
PEG (5Y)0.88
EPS Next 2Y13.56%
EPS Next 3Y14%

4

5. Dividend

5.1 Amount

ESF0 has a Yearly Dividend Yield of 1.01%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 0.74, ESF0 pays a better dividend. On top of this ESF0 pays more dividend than 88.89% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, ESF0's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.01%

5.2 History

The dividend of ESF0 is nicely growing with an annual growth rate of 16.51%!
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
ESF0.DE Yearly Dividends per shareESF0.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

ESF0 pays out 54.91% of its income as dividend. This is a bit on the high side, but may be sustainable.
ESF0's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP54.91%
EPS Next 2Y13.56%
EPS Next 3Y14%
ESF0.DE Yearly Income VS Free CF VS DividendESF0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ESF0.DE Dividend Payout.ESF0.DE Dividend Payout, showing the Payout Ratio.ESF0.DE Dividend Payout.PayoutRetained Earnings

EUROFINS SCIENTIFIC

FRA:ESF0 (11/18/2025, 7:00:00 PM)

58.06

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-21 2025-10-21
Earnings (Next)01-28 2026-01-28/amc
Inst Owners37.21%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap10.58B
Revenue(TTM)6.89B
Net Income(TTM)374.80M
Analysts69.47
Price Target64.54 (11.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.01%
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.91%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.09%
PT rev (3m)-0.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.09%
EPS NY rev (3m)-0.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-0.84%
Valuation
Industry RankSector Rank
PE 16.13
Fwd PE 14.58
P/S 1.53
P/FCF 13.49
P/OCF 8.04
P/B 2.28
P/tB N/A
EV/EBITDA 8.2
EPS(TTM)3.6
EY6.2%
EPS(NY)3.98
Fwd EY6.86%
FCF(TTM)4.3
FCFY7.41%
OCF(TTM)7.22
OCFY12.43%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.1
PEG (5Y)0.88
Graham Number45.4
Profitability
Industry RankSector Rank
ROA 3.54%
ROE 8.09%
ROCE 12.64%
ROIC 9.79%
ROICexc 10.74%
ROICexgc 34.1%
OM 15.59%
PM (TTM) 5.44%
GM 23.29%
FCFM 11.37%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexgc growth 3Y-18.17%
ROICexgc growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 5.25
Debt/EBITDA 2.1
Cap/Depr 84.94%
Cap/Sales 7.7%
Interest Coverage 9.93
Cash Conversion 77.37%
Profit Quality 209.21%
Current Ratio 1.26
Quick Ratio 1.19
Altman-Z 2.63
F-Score7
WACC7.93%
ROIC/WACC1.23
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y14.65%
EPS Next 2Y13.56%
EPS Next 3Y14%
EPS Next 5Y15.6%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.91%
Revenue Next 5Y7.37%
EBIT growth 1Y14.03%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year86.11%
EBIT Next 3Y30.34%
EBIT Next 5Y22.42%
FCF growth 1Y113.13%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.31%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%

EUROFINS SCIENTIFIC / ESF0.DE FAQ

Can you provide the ChartMill fundamental rating for EUROFINS SCIENTIFIC?

ChartMill assigns a fundamental rating of 6 / 10 to ESF0.DE.


Can you provide the valuation status for EUROFINS SCIENTIFIC?

ChartMill assigns a valuation rating of 7 / 10 to EUROFINS SCIENTIFIC (ESF0.DE). This can be considered as Undervalued.


What is the profitability of ESF0 stock?

EUROFINS SCIENTIFIC (ESF0.DE) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for ESF0 stock?

The Earnings per Share (EPS) of EUROFINS SCIENTIFIC (ESF0.DE) is expected to grow by 14.65% in the next year.


Can you provide the dividend sustainability for ESF0 stock?

The dividend rating of EUROFINS SCIENTIFIC (ESF0.DE) is 4 / 10 and the dividend payout ratio is 54.91%.